According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR), sentiment of U.S. newspaper articles covering lung cancer screening (LCS) from 2010 to 2022 was overall positive; however, certain key elements of LCS were infrequently mentioned

Line graph depicting number of U.S. newspaper articles covering LCS by year of publication, 2010-22. Key developments in lung cancer screening are annotated by year. Study period included only first 3 months of 2022, resulting in lower number of articles for that year. LCS = lung cancer screening. NLST = National Lung Screening Trial, USPSTF = U.S. Preventive Services Task Force, LDCT = low-dose CT, AAFP = American Academy of Family Physicians.


March 15, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR), sentiment of U.S. newspaper articles covering lung cancer screening (LCS) from 2010 to 2022 was overall positive; however, certain key elements of LCS were infrequently mentioned. 

“The findings highlight areas for potential improvement of LCS media coverage; radiologists have an opportunity to take a more active role in this coverage,” concluded first author Brent P. Little, MD, of Mayo Clinic Florida in Jacksonville. 

Little et al. searched the ProQuest U.S. Newsstream database for news articles regarding LCS that were published from January 1, 2010—when National Lung Screening Trial results were published—to March 28, 2022. Their search included the following terms: lung cancer screening(s), lung screening(s), low dose screening(s), and LDCT. Results were reviewed to identify those articles mentioning LCS. After extracting article origination and characteristics, articles were then divided among nine independent readers to assess article sentiment regarding LCS, as well as additional content, using a standardized form. 

Ultimately, among 859 U.S. newspaper articles pertaining to LCS from 2010 to 2022, 76% had a positive sentiment regarding LCS. Enrollment criteria, smoking cessation programs, need for annual CT, shared decision making, and cost issues were mentioned in 4% to 52% of articles. Moreover, a radiologist was interviewed or mentioned in 9%. 

“Radiologists should recognize common deficiencies in newspaper coverage of LCS and take a more active role to optimize media coverage of this important imaging service,” the authors of this AJR accepted manuscript concluded

For more information: www.arrs.org 


Related Content

News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | Artificial Intelligence

July 22, 2024 — Healthcare artificial intelligence (AI) systems provider, Qure.ai, has announced its receipt of a Class ...

Time July 22, 2024
arrow
News | Radiation Therapy

July 22, 2024 — RefleXion Medical, an external-beam theranostic oncology company, today announced that researchers from ...

Time July 22, 2024
arrow
News | ASTRO

July 18, 2024 — The members of the American Society for Radiation Oncology (ASTRO) recently elected five new officers to ...

Time July 18, 2024
arrow
News | PET-CT

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
News | Digital Pathology

July 12, 2024 — AGFA HealthCare, a global leader in healthcare imaging management solutions, announced that Enterprise ...

Time July 12, 2024
arrow
News | Digital Pathology

July 12, 2024 — Diagnosing cancer and providing the personalized therapy it often requires, is a collaborative effort ...

Time July 12, 2024
arrow
Feature | Imaging Technology News - ITN

Be sure to check out the latest digital edition of Imaging Technology News (ITN), featuring the Mobile C-arm Systems ...

Time July 11, 2024
arrow
Feature | Radiology Business

ITN conducts a bi-monthly survey to its readers on a variety of topics, which is used to create the Last Read, a unique ...

Time July 08, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
Subscribe Now